DiaSorin S.p.A. (IT:DIA) has released an update. DiaSorin S.p.A. reported a strong performance for the first nine months of 2024, with revenues reaching €876 million, a 4% increase at constant ...

NEW YORK – Diasorin reported on Tuesday that its third quarter revenues rose 6 percent year over year with rising demand for the firm's immunodiagnostic assays in the US and Europe. At constant ...

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...